Skip to main content
. 2023 Jun 17;14:3605. doi: 10.1038/s41467-023-39292-w

Fig. 5. Schematic of the COV-2069 mAb prevention trial and mRNA-1273 vaccine trial (COVE) as analyzed in this report.

Fig. 5

Both trials were conducted before the emergence of the Omicron VOC in trial participants, had similar populations, enrolled SARS-CoV-2 naïve individuals, and had similar definitions of symptomatic COVID-19 illness.